Retinal toxicity in long term hydroxychloroquine treatment

Annals of the Rheumatic Diseases

Volumn 55, Issue 3, 1996, Pages 187-189

  Mavrikakis, Myron ^a   Papazoglou, Sotirios ^b   Sfikakis, Peter P ^c   Vaiopoulos, George ^d   Rougas, Kostantinos ^e  

^a ALEXANDRA HOSPITAL   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

^d First Dept of Internal Medicine

^e Athens Eye Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETINOPATHY; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029968183     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.3.187     Document Type: Article

References (13)

1. Wallace D J. Antimalarial therapies. In: Wallace D J, Hahn B H, eds. Dubois' Lupus Erythematosus, 4th edn. Philadelphia: Lea & Febiger, 1993; 563-73.
2. Felson D T, Anderson J J, Meenan R F. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum 1990; 33: 1449-61.
3. Wallace D J. Antimalarial agents and lupus. Rheum Dis Clin N Am 1994; 20: 243-64.
4. Fox R I. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum 1993; 23: 82-91.
5. Stafford-Brady F J, Urowitz M B, Gladman D D, Easterbrook M. Lupus retinopathy. Arthritis Rheum 1988; 31: 1105-10.
6. Finbloom D, Silver K, Newsome E, Gunkel R. Comparison of hydroxychloroquine and chloroquine use in the development of retinal toxicity. J Rheumatol 1985; 12: 692-4.
7. Bernstein H N. Ocular safety of hydroxychloroquine. Ann Opthalmol 1991; 23: 292-6.
8. Bernstein H N. Ocular safety of hydroxychloroquine sulfate. South Med J 1992; 85: 274-8.
9. Weiner A, Sandberg M A, Gaudio A R, Kini M M, Berson E L. Hydroxychloroquine retinopathy. Am J Opthalmol 1991; 112: 528-34.
10. Easterbrook M. The ocular safety of hydroxychloroquine. Semin Arthritis Rheum 1993; 23: 62-7.
11. Mackenzie A H. Dose refinements in long-term therapy of rheumatoid arthritis antimalarials. Am J Med 1983; 18: 40-5.
12. Lanham J G, Hughes G R V. Antimalarial therapy in SLE. Clin Rheum Dis 1982; 8: 279-98.
13. Morsman C D, Livesey S J, Richards I M, Jessop J D, Mills P V. Screening for hydroxychloroquine retinal toxicity: is it necessary? Eye 1990; 4: 572-6.